Phio Pharmaceuticals Corp - Warrants (21/12/2021)
PHIOW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$269.52K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $269,520.00 |
|---|---|
| Enterprise Value | $-12,726,480.00 |
| Earnings per Share | $-1.45 |
| Beta | 0 |
| Outstanding Shares | 11,617,250 |
Return
| Return on Equity | -102.40% |
|---|---|
| Return on Assets | -90.19% |
| Return on Invested Capital | -18.92% |
Valuation & Multiples
| P/E Ratio | -0.64 |
|---|---|
| PEG | -0.7 |
| Price to Sales | - |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.19 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Phio Pharmaceuticals Corp
10 employees
CEO: Gerrit Dispersyn
Phio Pharmaceuticals Corp. is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic platform. The Company's efforts are focused on silencing tumor-...